Coyne Terrance P. sold RPRX
August 7, 2026 · Form 4 insider transaction
Coyne Terrance P. sold 18,500 shares of Royalty Pharma plc at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
No Class E Ordinary Shares of RPH ("Class E Shares") are being converted by the Reporting Person. Class E Shares are subject to vesting conditions. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion.